Beijing Biostar Pharmaceuticals (02563) Publishes Monthly Return for October 2025
Bulletin Express
Nov 03
Beijing Biostar Pharmaceuticals Co., Ltd. (02563) submitted its Monthly Return on Movements in Securities for the period ended 31 October 2025. The company reported that its total registered share capital remained unchanged at RMB 364,588,000, consisting of 216,720,857 H shares listed on the Hong Kong Stock Exchange and 147,867,143 unlisted shares, each with a par value of RMB 1.
No changes were noted in the number of issued shares, and there were no treasury shares or other share-related transactions (including share options, warrants, convertibles, or other arrangements) during the month. The submission was filed on 3 November 2025, with no amendments to previously reported figures.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.